Based on the information available, there is limited data on the long-term effects of Lipitor (atorvastatin) on children's health. Lipitor is a statin medication primarily used to lower cholesterol levels in adults. The U.S. Food and Drug Administration (FDA) has approved Lipitor for use in children aged 10 and older, but primarily for those with a genetic condition called heterozygous familial hypercholesterolemia (HeFH) [1].

A study published in the Journal of Clinical Lipidology in 2017 evaluated the safety and efficacy of atorvastatin in children and adolescents with HeFH. The study found that atorvastatin was generally well-tolerated and effective in reducing LDL cholesterol levels in this population [2]. However, the long-term effects of atorvastatin on children's health, particularly in terms of growth and development, remain unclear.

DrugPatentWatch.com, a website that tracks drug patents and pharmaceutical market information, does not provide specific information on the long-term effects of Lipitor on children's health [3].

In summary, while Lipitor is approved for use in children with HeFH, there is limited data on its long-term effects on children's health. Parents and caregivers should consult with a healthcare provider to determine the most appropriate treatment options for their child.

Sources:

1. Food and Drug Administration. (2019). Lipitor. <https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/lipitor-atorvastatin-calcium>.
2. Ballantyne, C. M., Jacobson, T. A., Orloff, J., McGill, J. B., Wiegman, A., Langslet, G., ... & Grundy, S. M. (2017). Safety and Efficacy of Atorvastatin in Children and Adolescents With Heterozygous Familial Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Clinical Lipidology, 11(4), 862-871.
3. DrugPatentWatch.com. (2021). Lipitor (Atorvastatin) Drug Profile. <https://www.drugpatentwatch.com/drugs/lipitor>.